Navigation Links
National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting
Date:8/5/2008

with HIV/AIDS, these diseases, along with HVB, are major health challenges for the nation. Patients require complex and coordinated care, made more challenging because many have additional complicated conditions.

Cindy Weinbaum, MD, MPH, team leader at the Prevention Research and Evaluation Division of Viral Hepatitis, Centers for Disease Control & Prevention, and Fred Rachman, MD, chief executive officer and chief medical officer at the Alliance of Chicago Community Health Services, co-chaired NQF's steering committee on clinician-level infectious diseases.

"Given the known gaps and variations in care for patients infected with HIV/AIDS and Hepatitis B and C, it is imperative that the medical community begin to systematically measure itself at the individual clinician- and system-level to identify where improvement efforts are needed," said Rachman. "The NQF process is instrumental for endorsing a single set of consensus standards that will help alleviate the multiple, competing sets of measures for HIV/AIDS and hepatitis against which clinicians are currently measured. This supports our ultimate aim - a uniform standard of care that every consumer can expect."

Measures were developed by the American Medical Association's Physician Consortium for Performance Improvement, the Asian Liver Center at Stanford University, and the National Committee for Quality Assurance.

Perioperative Care

Seventeen new NQF-endorsed voluntary consensus standards include clinician-level and facility-level performance measures for critical care and anesthesiology; perioperative management; and general thoracic surgery. Additionally, prophylactic antibiotic measures previously endorsed by NQF were updated to include foot and ankle procedures.

Darrell Campell, MD, professor of surgery and chief of staff at University of Michigan Hospitals and Health Centers, and Rome Walker, MD, medical director at Anthem Blue Cross Blue Shield in Virginia, co-chai
'/>"/>

SOURCE National Quality Forum
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... 26, 2014 DW-InductionHeating.com (DaWei Induction Heating ... researching and developing, producing and marketing of a series ... business announces their new series of induction brazing ... the company, induction brazing refers to the ... filler material and heat. The manager says that there ...
(Date:12/25/2014)... December 26, 2014 The microscopy ... of 7.2% to reach $5,756.0 million by 2019. ... microscopy market. The electron microscopes product segment is ... forecast period. , Rising focus on nanotechnology, technological ... of the microscopy market. , Get Full Copy ...
(Date:12/25/2014)... The click strand woven bamboo ... durability. Today, the business announces a click strand ... Jan. 30, 2015. , Click strand woven bamboo ... is a well-known brand in the bamboo industry. ... a reliable bamboo flooring supplier. , “We are ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 The ... to 2023” focuses on the current treatment landscape, unmet ... cancer market. TS-1 is an anti-cancer drug which is ... orally and is also used for treating gastric cancer ... and otastat potassium. The drug was first approved in ...
(Date:12/25/2014)... “Every three months the trends for ... evening dress will be one of the hottest styles in ... says. Today, the company releases 26 A-line sweetheart evening dresses, ... off. , “We are trying our best to help ... latest designs. Along with affordable prices, we provide discounted delivery ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... Dec. 6 - Atlantic Information,Services, Inc. (AIS) -- ... Benefit News and Specialty Pharmacy News has just,released ... For the,past eight years, AIS has been surveying ... the results to track trends in this,volatile industry. ...
... do you get for the nut,that has everything, including more ... Chuck talking therapy doll?, You can at once give ... needs it, their own personal and portable psychotherapist. The,Ask Doctor ... which could,earn you the undying gratitude of the rest of ...
... ALISO VIEJO, Calif., Dec. 6 Clarient, Inc.,(Nasdaq: ... resource for,pathologists, oncologists and the pharmaceutical industry, today ... in a panel discussion,titled "From Discovery To Diagnosis: ... Capital Markets 2007 Healthcare Conference at 3:30 p.m.,EST ...
... Unveiled in Ongoing Preparation for Commercial Launch, ... Inc. (Nasdaq:,FVRL), a biopharmaceutical company developing patient-specific, ... that new data,including four-year follow-up data from ... (formerly FavId(R)), will be reported in four,separate ...
... and OMX Nordic Exchange: EPCT) today announced that ... overview at the New York Society,of Security Analysts ... December 12, 2007 at 4:05 p.m. Eastern Time. ... at 1177 Avenue of the Americas in,New York ...
... Be Presented at 2008 Convention, BALTIMORE, Dec. ... launched the Dr. Jacob Bolotin Award Program. Beginning ... present cash awards to,individuals and organizations that have ... the blind into society on a basis,of equality., ...
Cached Medicine News:Health News:2000-2007 Pharmacy Benefit Survey Results Just Released 2Health News:The Cure for Holiday Stress 2Health News:Clarient CEO Andrews to Participate in Panel Discussion at the RBC Capital Markets 2007 Healthcare Conference 2Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 2Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 3Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 4Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 5Health News:EpiCept Corporation to Present at The New York Society of Security Analysts 11th Annual Biotech & Specialty Pharma Conference 2Health News:EpiCept Corporation to Present at The New York Society of Security Analysts 11th Annual Biotech & Specialty Pharma Conference 3Health News:National Federation of the Blind to Award $100,000 2
(Date:12/24/2014)... and RALEIGH, N.C. , Dec. ... Endo International plc (NASDAQ: ENDP ) (TSX: ... BDSI ) announced today that they have submitted a ... to the U.S. Food and Drug Administration (FDA).  Buprenorphine ... of pain severe enough to require daily, around-the-clock, long-term ...
(Date:12/22/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/h3xm6q/us ) has ... Glucose Market" report to their offering. ... insight focuses on the developments in the self-monitoring blood ... . Reimbursement analysis and the effects of competitive bidding ... 73 SMBG meters have been performed, based on the ...
(Date:12/22/2014)... STOCKHOLM , Dec. 22, 2014 Swedish ... Inc. today announced that the Committee for Medicinal Products ... (EMA) has adopted a positive opinion for the use ... adult men with Peyronie,s disease with a palpable plaque ... the start of therapy. The use of ...
Breaking Medicine Technology:Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5US Self-monitoring Blood Glucose Market 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6
... CLARKSVILLE, Md., Nov. 4 Neuronascent, Inc., a ... for the treatment of depression, Alzheimer,s disease, Parkinson,s ... into a discovery agreement with ChemRar Pharma, a ... for developmental pathways and stem cells to treat ...
... 3 WebMD Health Corp. (Nasdaq: WBMD ) announced today ... purchase up to 5,700,000 shares of its common stock at a ... per share of WebMD,s common stock on the Nasdaq Global Select ... number of shares proposed to be purchased in the tender offer ...
Cached Medicine Technology:Neuronascent Announces Collaboration with ChemRar for Characterization of Developmental Pathway Inhibitors Using Neuronascent's Neurogenesis Platform 2WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock 2WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock 3
... Accu-Temp Cauteries provide a broad selection ... a wide variety of ophthalmic procedures. ... sterile, complete with a safety cap ... " position when not in use, ...
... a broad selection of tip styles ... of ophthalmic procedures. Each single use ... a safety cap to lock switch ... not in use, and carries a ...
... provide the surgeon with an indirect illumination ... be easily visualized through the laser microscope. ... light scatter technique, the surgeon can enhance ... edge folds, corneal flap striae and flap ...
... system allows you access to the most ... system includes 10 different optotypes, crowding bars, ... characters. Random character sequencing eliminates memorization. In ... line and multiple line selection capability. The ...
Medicine Products: